Description
BPC-157 + KPV Dual-Peptide Capsules combine two extensively-characterized research peptides in a single oral capsule format — 500 micrograms of BPC-157 (Body Protection Compound-157, a pentadecapeptide fragment from gastric juice research characterized by Sikiric and colleagues at the University of Zagreb) plus 500 micrograms of KPV (Lys-Pro-Val, the C-terminal tripeptide fragment corresponding to α-MSH residues 11-13). This dual-peptide combination represents a research format bringing together two peptides with distinct but complementary research mechanisms: BPC-157 has been extensively investigated in academic literature for gastric peptide chemistry, tissue repair research, and cytoprotective pathway research, while KPV has been characterized as an α-MSH C-terminal fragment research compound for cytokine pathway research and NF-κB signaling cascade studies. The oral capsule format uses microcrystalline cellulose (MCC) as the standard capsule excipient in a gelatin capsule shell. This 30 capsule bottle provides 1mg total dual-peptide content per capsule (500mcg BPC-157 + 500mcg KPV) for laboratory research applications investigating combined gastric peptide and α-MSH tripeptide research, oral peptide chemistry, and comparative pharmacology versus single-peptide research administration.
Benefits (Research Focus)
• Combined dual-peptide research — studied as a two-peptide combination for comparative pharmacology versus single-peptide BPC-157 and single-peptide KPV administration
• Gastric peptide chemistry research — investigated for BPC-157 gastric peptide fragment research applications
• α-MSH C-terminal fragment research — explored for KPV α-MSH residues 11-13 fragment research applications
• Cytokine pathway research — examined for KPV-mediated TNF-α and IL-6 cytokine pathway research in cell research models
• Oral peptide chemistry research — researched as an oral capsule format combining two research peptides for comparative research versus single-peptide oral capsule formats
What Researchers Look At
• Comparative pharmacology versus single-peptide BPC-157 administration and single-peptide KPV administration
• Combined dual-peptide oral capsule stability and dissolution characterization
• Gastric stability of BPC-157 and KPV in oral formulation research
• Comparative research versus KLOW quad-peptide blend (which also contains BPC-157 and KPV alongside TB-500 and GHK-Cu)
• Two-peptide combination research applications in cell research models
Quick Specs
• Form: Gelatin capsule
• Strength: 1 mg total dual-peptide per capsule
• BPC-157 per Capsule: 500 mcg (0.5 mg)
• KPV per Capsule: 500 mcg (0.5 mg)
• Quantity: 30 capsules per bottle
• Total BPC-157 per Bottle: 15 mg
• Total KPV per Bottle: 15 mg
• Other ingredients: Microcrystalline cellulose (MCC, excipient), gelatin capsule shell
• Appearance: Standard gelatin capsule presentation
• Purity: ≥99% (each peptide component)
• Identity: MS-verified (per COA)
• Storage: Protect from light
Identity Basics — Component Peptides
• BPC-157: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val (15 amino acids) — Body Protection Compound-157, gastric peptide fragment (Sikiric, University of Zagreb)
• KPV: Lys-Pro-Val (3 amino acids) — α-MSH C-terminal tripeptide corresponding to α-MSH residues 11-13
• Class: Dual-peptide oral research capsule combining two distinct peptide research classes (pentadecapeptide gastric fragment + α-MSH tripeptide fragment)
• Combination rationale: Two research peptides with distinct mechanisms combined in a single oral capsule research format
• Total peptide content per capsule: 1 mg (500 mcg BPC-157 + 500 mcg KPV)
• CAS: BPC-157 CAS 137525-51-0; KPV CAS 27210-24-0
⚠️ Disclaimer
- This product is intended for laboratory research use only.
- Not for human or veterinary use.
- Not approved for diagnostic, therapeutic, or medical applications.
- Handle using appropriate laboratory safety procedures and personal protective equipment.
COA Verification Notice: Even if the capsule label or product image states a certain concentration, always go by the COA for the true verified value. We reference the COA to determine the verified concentration and purity of each batch, regardless of what the label or product image indicates.
Janoshik COA — Third-Party Testing
• [COA links for the BPC-157 + KPV dual-peptide 30 capsule batch to be added once Janoshik testing is complete]
